[1] SCHEEFF D E,BOURNE P E.Structural evolution of the protein kinase-like superfamily[J].PLoS Computational Biology,2005,1(5):359-381.
[2] FALASCA M,MAFFUCCI T.Role of class Ⅱ phosphatidylinositol 3-kinase in cell signalling[J].Biochemical Society Symposia,2007,35(2):211-214.
[3] VANHAESEBROECK B,GUILLERMET-GUIBERT J,GRAUPERA M,et al.The emerging mechanisms of isoform-specific PI3K signalling[J].Nature Reviews Molecular Cell Biology,2010,11(5):329-341.
[4] YAN Y,BACKER J M.Regulation of class Ⅲ (Vps34) PI3Ks[J].Biochemical Society Transactions,2007,35(2):239-241.
[5] MILLER S,TAVSHANJIAN B,OLEKSY A,et al.Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34[J].Science,2010,327:1638-1642.
[6] KUMAR C C,MADISON V.AKT crystal structure and AKT-specific inhibitors[J].Oncogene and Oncogene Reviews,2005,24(50):7493-7501.
[7] MARONE R,CMILJANOVIC V,GIESE B,et al.Targeting phosphoinositide 3-kinase:moving towards therapy[J].Biochimica et Biophysica Acta:Proteins and Proteomics,2008,1784(1):159-185.
[8] ENGELMAN J A,LUO J,CANTLEY L C.The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[J].Nature Reviews Genetics,2006,7:606-619.
[9] YU J,WJASOW C,BACKER J M.Regulation of the p85/p110 alpha phosphatidylinositol 3-kinase.Distinct roles for the n-terminal and c-terminal SH2 domains[J].Journal of Biological Chemistry,1998,273(46):30199-30203.
[10] STOYANOV B,VOLINIA S,HANCK T,et al.Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase[J].Science,1995,269:690-693.
[11] JIA S,LIU Z,ZHANG S,et al.Essential roles of PI(3)K-p110beta in cell growth,metabolism and tumorigenesis[J].Nature,2008,454:776-779.
[12] STEPHENS L R,EGUINOA A,ERDJUMENT-BROMAGE H,et al.The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor,p101[J].Cell,1997,89(1):105-114.
[13] KURIG B,SHYMANETS A,BOHNACKER T,et al.Ras is an indispensable coregulator of the class ⅠB phosphatidylinositol 3-kinase p87/p110 gamma[J].Proceedings of the National Academy of Sciences of the United States of America,2009,106(48):20312-20317.
[14] BROCK C,SCHAEFER M,REUSCH H P,et al.Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphatidylinositol 3-kinase gamma[J].Journal of Cell Biology,2003,160(1):89-99.
[15] SUIRE S,COADWELL J,FERGUSON G J,et al.p84,a new gbetagamma-activated regulatory subunit of the type ⅠB phosphatidylinositol 3-kinase p110gamma[J].Current Biology,2005,15(6):566-570.
[16] PACOLD M E,SUIRE S,PERISIC O,et al.Crystal structure and functional analysis of Ras binding to its effector phosphatidylinositol 3-kinase gamma[J].Cell,2000,103(6):931-943.
[17] VADAS O,BURKE J E,ZHANG X X,et al.Structural basis for activation and inhibition of class Ⅰ phosphoinositide 3-kinases[J].Science Signal,2011,4(195):1-12.
[18] OSAKI M,OSHIMURA M,ITO H.PI3K-Akt pathway:its functions and alterations in human cancer[J].Apoptosis,2004,9(6):667-676.
[19] SONG G,OUYANG G,BAO S.The activation of Akt/PKB signaling pathway and cell survival[J].Journal of Cellular and Molecular Medicine,2005,9(1):59-71.
[20] THOOMPSON J E,THOMPSON C B.Putting the Rap on Akt[J].Journal of Clinical Oncology,2004,22(20):4217-4226.
[21] JIA G,MITRA A K,GANGAHAR D M,et al.Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein[J].Experimental and Molecular Pathology,2010,89(1):20-26.
[22] ZHOU H L,LI X M,MEINKOTH J,et al.Akt regulates cell survival and apoptosis at a postmitochondrial level[J].The Journal of Cell Biology,2000,151(3):483-494.
[23] MATSAKAS A,PATEL K.Skeletal muscle fibre plasticity in response to selected environmental and physiological stimuli[J].Histology and Histopathology,2009,24(5):611-629.
[24] DUPONT E,BERNARD C C,BASTIDE B,et al.Electrostimulation during hindlimb unloading modulates PI3K-AKT downstream targets without preventing soleus atrophy and restores slow phenotype through ERK[J].American Journal of Physiology:Regulatory,Integrative and Comparative Physiology,2011,300:408-417.
[25] LUO J,SOBKIW C L,HIRSHMAN M F,et al.Loss of class ⅠA PI3K signaling in muscle leads to impaired muscle growth,insulin response,and hyperlipidemia[J].Cell Metabolism,2006,3:355-366.
[26] ALISI A,SPAZIANI A,ANTICOLI S,et al.PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways[J].Cellular Signalling,2008,20(3):534-542.
[27] ELIA D,MADHALA D,ARDON E,et al.Sonic hedgehog promotes proliferation and differentiation of adult muscle cells:involvement of MAPK/ERK and PI3K/Akt pathways[J].Biochimica et Biophysica Acta,2007,1773(9):1438-1446.
[28] ROFFE S,HAGAIA Y,PINES M,et al.Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells:effect on myotube fusion[J].Experimental Cell Research,2010,316:1601-1609.
[29] BAVIERA A M,ZANON N M,NAVEGANTES L C C,et al.Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle[J].Molecular and Cellular Endocrinology,2010,315(1/2):104-112.
[30] GLASS D J.Molecular mechanisms modulating muscle mass[J].Trends in Molecular Medicine,2003,9(8):345-350.
[31] ZHANG H,STALLOCK J P,JOYCE C N,et al.Regulation of cellular growth by the drosophila target of rapamycin dTOR[J].Genes and Development,2000,14:2712-2724.
[32] PALLAFACCHINA G,CALABRIA E,SERRANO A L,et al.A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99(14):9213-9218.
[33] OHANNA M,SOBERING A K,LAPOINTE T,et al.Atrophy of S6K1(-/-)skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control[J].Nature Cell Biology,2005,7(3):286-294.
[34] KUBICA N,BOLSTER D R,FARRELL P A,et al.Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2B epsilon mRNA in a mammalian target of rapamycin-dependent manner[J].The Journal of Biological Chemistry,2005,280(9):7570-7580.
[35] VYAS D R,SPANGENBURG E E,ABRAHA T W,et al.GSK-3beta negatively regulates skeletal myotube hypertrophy[J].American Journal of Physiology,2002,283(2):545-551.
[36] KAWANO Y,KYPTA R.Secreted antagonists of the Wnt signalling pathway[J].Journal of Cell Science,2003,116:2627-2634.
[37] ROCHAT A,FERNANDEZ A,VANDROMME M,et al.Insulin and Wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy[J].Molecular Biology of the Cell,2004,15:4544-4555.
京公网安备 11010802041926号